Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lester J Peters

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Medical Imaging and Radiation Oncology|April 20, 2011
Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancerJune Corry, Danny Rischin, Sue Cotton, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluationRodney J Hicks, Michael P Mac Manus, Jane P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2014
Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancerDamien C Weber, Coen W Hurkmans, Christos Melidis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinomaRichard J Young, Danny Rischin, Richard Fisher, et al.
Head & Neck|October 14, 2015
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinomaDamien Urban, June Corry, Ben Solomon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neckTiffany Daly, Michael G Poulsen, James W Denham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology GroupDanny Rischin, Lester J Peters, Brian O'Sullivan, et al.
Journal of Medical Imaging and Radiation Oncology|February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancerMateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck CancerDavid I Rosenthal, Abdallah S R Mohamed, Adam S Garden, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Medical Imaging and Radiation Oncology|April 20, 2011
Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancerJune Corry, Danny Rischin, Sue Cotton, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluationRodney J Hicks, Michael P Mac Manus, Jane P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2014
Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancerDamien C Weber, Coen W Hurkmans, Christos Melidis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinomaRichard J Young, Danny Rischin, Richard Fisher, et al.
Head & Neck|October 14, 2015
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinomaDamien Urban, June Corry, Ben Solomon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neckTiffany Daly, Michael G Poulsen, James W Denham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology GroupDanny Rischin, Lester J Peters, Brian O'Sullivan, et al.
Journal of Medical Imaging and Radiation Oncology|February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancerMateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2017
Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck CancerDavid I Rosenthal, Abdallah S R Mohamed, Adam S Garden, et al.
Pageof 5